振东制药 (300158.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(振东制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 782,130,269.053,626,016,132.882,783,745,444.641,932,888,842.05951,417,159.093,728,555,341.192,799,161,844.041,725,633,992.62888,836,734.49
 营业利润(元) 32,289,666.48-29,983,444.1211,737,348.5028,582,148.977,304,228.83-5,920,388.6168,836,114.8157,930,472.4318,066,566.92
 利润总额(元) 30,993,193.10-37,692,657.9611,157,389.3029,490,042.117,442,110.73-5,280,478.5167,187,094.5055,766,180.8318,051,241.57
 净利润(元) 22,347,124.36-47,869,202.52-4,134,073.5912,209,320.25-902,065.90-56,998,843.7120,892,626.2122,923,862.767,814,690.78
 归属于母公司股东的净利润(元) 23,101,557.95-43,984,116.23-874,204.9214,542,410.37-394,728.53-51,290,041.0624,744,473.2524,645,360.279,149,858.74
盈利能力:
 销售毛利率(%) 44.3950.3750.8049.1546.9949.3150.5150.4048.40
 销售净利率(%) 2.86-1.32-0.150.63-0.09-1.530.751.330.88
 净资产收益率(%) 0.45-0.84-0.020.28-0.01----
 总资产报酬率ROA(%) 0.49-0.740.050.340.08----
 投入资本回报率ROIC(%) 0.45-0.84-0.020.27-0.01-0.750.360.350.11
营运能力:
 存货周转率(次) 0.361.591.160.880.45----
 应收账款周转率(次) 1.165.453.892.771.23----
 总资产周转率(次) 0.130.570.430.290.12----
偿债能力:
 资产负债率(%) 15.0816.7715.5216.0818.7920.2723.7826.7920.21
 股东权益比率(%) 85.5283.7985.0484.4681.6980.2076.6473.5880.06
 已获利息倍数(倍) -68.034.94-0.42-3.40-6.650.477.007.067.68
 流动比率 5.344.865.375.194.374.043.463.264.65
 速动比率 3.763.443.743.733.082.992.532.483.98
发展能力:
 营业收入增长率(%) -17.79-2.75-0.5512.017.04-26.80-30.93-34.80-31.27
 营业利润增长率(%) 342.07-406.44-82.95-50.66-59.57-100.19-82.34-79.05-84.62
 税后利润增长率(%) 5,952.5214.24-103.53-40.99-104.31-101.96-92.34-88.83-90.63
 净资产增长率(%) -2.59-1.43-2.05-1.76-35.05-34.97-7.84-7.8540.86
 总资产增长率(%) -6.95-5.65-11.73-14.41-36.35-35.10-9.58-4.1233.03

前瞻产业研究院